Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biora Therapeutics Inc (BIOR)

Biora Therapeutics Inc (BIOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biora Therapeutics Inc 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 USA

www.bioratherapeutics.com Employees: 58 P: 833-727-2841

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Biora Therapeutics Inc. is a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond. Biora Therapeutics Inc., formerly known as Progenity Inc., is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 995
Enterprise Value, $K -12,235
Shares Outstanding, K 4,523
Float, K 2,212
% Float 48.92%
Short Volume Ratio 0.46
% of Insider Shareholders 51.08%
% of Institutional Shareholders 43.74%

Financials:

Annual Sales, $ 4 K
Annual Net Income, $ -124,120 K
Last Quarter Sales, $ 30 K
Last Quarter Net Income, $ -18,400 K
EBIT, $ -60,880 K
EBITDA, $ -58,720 K

Growth:

1-Year Return -98.37%
3-Year Return -99.95%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -6.08 on 11/14/24
Next Earnings Date 03/25/25
Earnings Per Share ttm -21.98
EPS Growth vs. Prev Qtr -73.71%
EPS Growth vs. Prev Year 18.93%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 10/18/24

BIOR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -332.47%
Profit Margin % 0.00%
Debt/Equity -0.18
Price/Sales 497.61
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -28.98
Interest Coverage -11.67
60-Month Beta 1.12
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar